Genta, Inc. (GNTA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA)

GNTA 2.300

+0.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Miljenko Zuanic	11/12/2004 10:59:53 PM
	of 1870

Roy presentation (lecture) was not on regular schedule for Friday. It must be late-breker section after 4 p.m. Aventis knows this data, so what is going on? Genasense(R) Update in Lung Cancer to Be Presented at XXII Chemotherapy Foundation Symposium Thursday November 11, 8:00 am ET BERKELEY HEIGHTS, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA - News) today announced that Genasense® (oblimersen sodium) Injection, the Company's lead anticancer compound will be featured in a presentation at the XXII Chemotherapy Foundation Symposium being held November 10-13, 2004 at the Marriott Marquis in New York, NY. ADVERTISEMENT Roy Herbst, MD, PhD, Associate Professor of Medicine, MD Anderson Cancer Center, will present "Bcl-2 Antisense: New Developments in Lung Cancer" on Friday, November 12 at 4:40 p.m.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next